Hypoport

Hypoport SE (XETRA: HYQ) is a Berlin-based fintech operating Germany’s largest B2B credit, insurance, and corporate-finance technology platforms. The flagship asset is Europace, a marketplace for residential mortgages connecting over 800 German banks, savings banks (Sparkassen), cooperative banks (Volksbanken), and broker firms — Europace processes approximately 25 percent of all new German residential mortgage origination by volume. Secondary segments include Smart InsurTech (Germany’s largest B2B insurance-broker software platform with 10,000-plus broker firms as customers), Finmas (cooperative-bank mortgage platform), Genopace (Genossenschaftsbanken corporate-finance platform), and FIO (real-estate-broker software).

CEO Ronald Slabke founded the company in 1999, took it public in 2007 on the Frankfurt Stock Exchange, and remains the controlling shareholder with approximately 36.5 percent of outstanding shares held through his investment vehicle Revenia GmbH. The 9.7 percent 52-week-position is the consequence of a 91 percent drawdown from the August 2021 all-time-high of approximately 619 EUR pre-split (218 EUR on the current split-adjusted basis): the German residential property market froze in 2022-2023 as the European Central Bank lifted its policy rate from 0 percent to 4 percent in 14 months, German 10-year Bund yields rose from minus 0.5 percent to plus 2.8 percent, and effective German mortgage rates moved from 1.0 percent in early 2022 to 4.2 percent by October 2023.

New mortgage origination volume across Germany collapsed from a 32 billion EUR monthly peak in 2021 to a 16 billion EUR monthly trough in mid-2023 — Europace’s transaction-volume-based revenue (the company collects roughly 0.20-0.25 percent of mortgage notional as platform fee) halved in tandem. The 2024-2025 recovery thesis is data-confirmed: Bundesbank monthly mortgage origination data shows new origination back to approximately 24 billion EUR per month in late 2025, up 50 percent from the trough. Hypoport’s Q3 2025 disclosure put Europace transaction volume at 25 percent above the 2023 nadir while still 30 percent below the 2021 peak — implying significant remaining recovery runway. Forward PE 13.4x is a deep discount to the 5-year history average of 38x (the multiple peaked at 90x in the 2021 bubble). Profit margin recovered from minus 1 percent in 2023 to plus 4.6 percent, earnings growth of 43.9 percent YoY in the latest quarter reflects operating leverage on platform fees — each additional euro of transaction volume drops to operating profit at approximately 35-40 percent marginal contribution.

There is no activist or hedge-fund concentration in Hypoport SE — the company is dominated by founder-CEO Ronald Slabke, who owns approximately 36.5 percent of outstanding shares through his investment vehicle Revenia GmbH. This level of founder ownership is rare among German listed fintechs and is the single most important governance signal: Slabke has been CEO for 27 years, founded the company, and has zero incentive to dilute or asset-strip — his net worth is overwhelmingly tied to long-term equity compounding. Notable institutional shareholders include Allianz Global Investors (held 4.5 percent before the 2022-2023 drawdown, reduced position to approximately 3 percent during the 2023 sell-off), Union Investment (2.5 percent), DWS (1.8 percent), and German retail brokers (Comdirect, Trade Republic, ING DiBa retail flows).

Notable absences: no US hedge fund of size (Hypoport is too small for typical US small-cap funds focused on 1 billion USD-plus market cap), no activist (Slabke’s 36 percent stake is a blocking position against any 75 percent supermajority resolution under the German Stock Corporation Act, so activists do not pursue Hypoport), no Burry-style or Pabrai-style small-cap-value investors of note. The relevant insider-buying pattern in 2023-2024 trough: Slabke himself did not buy aggressively during the 68 EUR low (a mild yellow flag — he already owns 36 percent and has limited new-buying capacity), but CFO Stephan Gawarecki bought 5,000 shares at approximately 72 EUR in October 2023 (modest signal), and supervisory-board member Thilo Wersig bought 2,500 shares at 88 EUR in May 2024.

The analyst coverage is thin (only 4 analysts cover the stock) which is itself a setup feature — Berenberg Bank rates Buy with 195 EUR price target (135 percent upside from spot), Deutsche Bank Buy 215 EUR (160 percent upside), Hauck Aufhauser Lampe Buy 220 EUR, M.M. Warburg Buy 240 EUR. Consensus target 212.75 EUR implies 157 percent upside from the 82.75 EUR spot — a triple from current levels if Bundesbank mortgage origination normalizes back to 2021 levels.

At 82.75 EUR per share with 6.6 million diluted shares outstanding, Hypoport’s market capitalization is approximately 550 million EUR, and enterprise value (adjusting for 110 million EUR net debt and 30 million EUR balance-sheet cash) is approximately 630 million EUR. Trailing-twelve-month revenue of 612 million EUR puts EV/sales at 1.03x, EV/EBITDA at 15.5x on a normalized 40 million EUR EBITDA base, and trailing PE at 19.6x on a 28 million EUR net-income base. Forward PE 13.4x is the more relevant multiple because the operating leverage flowing from transaction-volume-recovery is mostly a 2026 phenomenon — consensus 2026 EPS is approximately 6.20 EUR per share, implying 13.4x on the 82.75 EUR spot.

Comparable German fintech multiples are illuminating: Hypoport’s nearest peer is Adesso SE (Germany IT services to financial-services), trading at 22x forward PE; SAP at 28x forward PE; check24 (private) was last valued at approximately 30x revenue. Within the German listed fintech universe, only Flatex Degiro at 14x forward PE trades at comparable discount to Hypoport. The 5-year historical Hypoport multiple range is 28-90x trailing PE (peak 2021 bubble) and 12-22x in normal cyclical bottom-to-mid conditions — current 19.6x trailing PE is mid-range despite earnings being trough-cycle, implying that as 2026 EPS normalizes upward, the multiple has room to expand to the upper end of the historical range. A sum-of-the-parts valuation, valuing Europace at 18x forward EBIT (consistent with two-sided-network-effect-marketplace comparables like Trustpilot, Auto Trader, and Rightmove), Smart InsurTech at 25x forward EBIT (vertical-SaaS comparable to Veeva, Tyler Technologies), and Finmas/Genopace/FIO at 12x forward EBIT, gives a per-share value of approximately 195-220 EUR — directly bracketed by the 212.75 EUR consensus target.

1. 2026 Q1:

   Q4 2025 earnings report (mid-February 2026) — critical data points are Europace transaction volume (consensus expects approximately 27 billion EUR Q4 versus 24 billion EUR Q3 2025 due to seasonal year-end mortgage closings), Q4 EBIT (consensus 8 million EUR versus 6 million EUR prior-year), and FY2026 guidance (consensus 35-40 million EUR EBIT versus 22 million EUR FY2025 estimate). Slabke’s commentary on broker-market-share gains versus direct-bank-origination channel is the highest-conviction directional signal — any guidance above 40 million EUR EBIT for FY2026 would catalyze a 25-35 percent re-rating toward the 110-130 EUR range over 4-6 weeks. Earnings release confirmed for February 17 2026.

2. 2026 H1:

   Bundesbank monthly mortgage origination data (released monthly with 6-week lag in the Money and Banking Statistics monthly bulletin). Each monthly data point above 26 billion EUR origination volume confirms the recovery thesis and tightens the gap toward the 32 billion EUR peak. The April 2026 release (reporting February 2026 data) will be particularly significant because Q1 is traditionally the seasonal trough for German mortgage origination — a Q1 reading above 25 billion EUR would confirm the structural-recovery thesis and unlock incremental analyst upgrades. Additionally, ECB rate-cut decisions in March and June 2026 Governing Council meetings: each 25-basis-point cut translates approximately to a 10-basis-point mortgage-rate compression and incremental volume tailwind.

3. 2026 H2:

   Capital Markets Day (typically held in September annually at Hypoport’s Berlin headquarters) where Slabke historically provides 3-year strategic outlook on Europace transaction-volume targets, Smart InsurTech recurring-revenue conversion progress, and capital allocation framework (M&A versus buyback versus dividend reinstatement). The 2026 CMD is expected to reset 2027-2028 EBIT guidance to a higher range — consensus already models EBIT at 60-70 million EUR for 2028 if recovery continues; an explicit Hypoport guidance of 70-80 million EUR would catalyze multiple expansion toward 18-20x forward PE on 2028 numbers, implying a 250-300 EUR price target over 18 months.

Hypoport is a founder-controlled German mortgage-tech platform with two-sided network-effects, mid-cycle valuation, and 157 percent consensus upside. The setup is unusually clean for a German small-cap fintech recovery: the macro driver (German mortgage origination recovery from 16 billion EUR to 32 billion EUR monthly) is mechanically tied to ECB rate normalization and is observable in real-time via Bundesbank monthly data — there is no information asymmetry on the recovery pace. The micro driver (Europace 25 percent national market share, founder-CEO Slabke 36 percent ownership, 4-analyst-coverage with 212 EUR consensus target) is structural. The bear case is bounded: a German housing-market relapse to 2023 trough volumes would compress earnings by 30-40 percent (Hypoport would still be profitable, just at 15 million EUR EBIT) and the stock would trade at 25x trough EPS (approximately 60-65 EUR) — a 20-25 percent downside from spot, not a catastrophic drawdown. The bull case is asymmetric: full recovery to 2021 transaction volumes implies 60-70 million EUR EBIT by 2027-2028, which at 18-20x forward PE prints 220-260 EUR per share — 165-215 percent upside. The asymmetry (down 20-25 percent versus up 165-215 percent) is roughly 7-to-1 on a 12-24 month horizon. Position-sizing matters because the stock is thinly traded — limit any single position to 2-3 percent of portfolio capital to avoid slippage on exit. Hypoport is a 2-3 percent position-size, 18-month-horizon contrarian recovery bet on German mortgage-market normalization with founder-led structural ownership protection — the recovery is happening, the multiple is dislocated, and the catalyst calendar is dense.